Exane Derivatives’s Corpay CPAY Stock Holding History

Exane Derivatives’s Portfolio CPAY Stock Details CPAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,834	Closed	-$796K	–	705
2019 Q2	$796K	Buy	2,834 +2,825	+31,389%	+$739K	0.14%	118
2019 Q1	$2.22K	Hold	9	–	–	﹤0.01%	440
2018 Q4	$1.67K	Hold	9	–	–	﹤0.01%	535
2018 Q3	$2.07K	Sell	9 -5,968	-100%	-$1.3M	﹤0.01%	493
2018 Q2	$1.26M	Buy	5,977 +5,974	+199,133%	+$1.23M	0.21%	101
2018 Q1	$583	Sell	3 -8,412	-100%	-$1.71M	﹤0.01%	496
2017 Q4	$1.62M	Buy	+8,415	New	+$1.48M	0.28%	60
2017 Q1	–	Sell	-128	Closed	-$18.1K	–	689
2016 Q4	$18.1K	Hold	128	–	–	﹤0.01%	372
2016 Q3	$22.2K	Hold	128	–	–	﹤0.01%	352
2016 Q2	$18.3K	Buy	+128	New	+$19K	﹤0.01%	336

Other funds holding CPAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Exane Derivatives's CPAY Position: Q3 2019 in Review

Exane Derivatives sold out of Corpay (CPAY) in Q3 2019, closing a stake of 2,834 shares — an estimated $796K sold.

Exane Derivatives first reported a position in CPAY in Q2 2016 and held it in 10 quarters. The position peaked at $1.62M in Q4 2017. 562 funds tracked by Wall St. Rank hold CPAY as of Q3 2019.

Exane Derivatives reported no remaining Corpay position as of Q3 2019 after selling out during the quarter.
Exane Derivatives sold 2,834 Corpay shares in Q3 2019, an estimated $796K.
Exane Derivatives first reported a position in Corpay in Q2 2016 and held it in 10 quarters.
Exane Derivatives's Corpay position peaked at $1.62M in Q4 2017.
562 funds tracked by Wall St. Rank held Corpay as of Q3 2019.

Based on Exane Derivatives's 13F filing for Q3 2019, filed 15 Oct 2019.